Inactive Instrument

Analyst Reco. DECHRA PHARMACEUTICALS LIMITED OTC Markets

Equities

DPHAY

US2434351043

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

Stifel Downgrades Dechra Pharmaceuticals to Hold from Buy, Lowers PT	27/06/23	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, GSK, Moderna, Smiths Group...	27/06/23
Jefferies Upgrades Dechra Pharmaceuticals to Buy from Hold, Lifts PT	18/10/22	MT
ANALYST RECOMMENDATIONS : Abbott Laboratories, Intel, JPMorgan, PepsiCo, Roblox...	18/10/22
ANALYST RECOMMENDATIONS : Domino's, Etsy, Goldman Sachs, Intel, Procter & Gamble...	05/10/22
Berenberg Starts Dechra Pharmaceuticals Coverage With Hold Rating	05/10/22	MT
ANALYST RECOMMENDATIONS : Accenture, Biogen, Fedex, Netflix, Philip Morris...	28/09/22
Jefferies Cuts Dechra Pharmaceuticals PT, Keeps Hold Rating	28/09/22	MT
RBC Trims Dechra Pharmaceuticals PT, Maintains Outperform Rating	15/09/22	MT
RBC Lifts Dechra Pharma to Outperform from Sector Perform, Trims PT	05/07/22	MT
Jefferies Reduces Dechra Pharmaceuticals PT, Keeps Hold Rating	26/04/22	MT
Liberum Lifts Dechra Pharmaceuticals To Hold From Sell	23/02/22	MT
ANALYST RECOMMENDATIONS : Anglo American, BP Plc, Cisco, Intel, Home Depot...	23/02/22
HSBC Keeps Dechra Pharmaceuticals At Buy, Cuts PT	22/02/22	MT
ANALYST RECOMMENDATION : Flutter, Foot Locker, GSK, Nike, On Holding...	21/02/22
JPMorgan Boosts Dechra Pharmaceuticals' PT, Keeps Overweight Rating	04/01/22	MT
ANALYST RECOMMENDATIONS : Columbia Sports, Halliburton, Match Group, Sherwin-Williams, Warner Music...	04/01/22
ANALYST RECOMMENDATIONS : American Express, Blackrock, Darktrace, Tullow Oil, Warner Music...	08/10/21
DECHRA PHARMACEUTICALS : JP Morgan Raises Dechra Pharmaceuticals PT, Keeps Overweight Rating	07/09/21	MT
DECHRA PHARMACEUTICALS : Liberum Boosts Dechra's PT, Affirms Sell Rating	07/09/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. DECHRA PHARMACEUTICALS LIMITED OTC Markets

Equities

DPHAY

US2434351043

Analyst Reco.

Filters